Understanding the Management of HER2+, Early-Stage Breast Cancer

In this episode of The Fellow on Call: The Heme/Onc Podcast: The Fellow on Call team shifts their focus from ER+ to HER+ breast cancer.  The group details:

• What is HER2?
• What is the mechanism of HER2?
• The discovery of trastuzumab
• The use of trastuzumab in adjuvant and neoadjuvant settings
• Highlights of key trials that shape the paradigm of management
• And much more